期刊文献+

人肝癌细胞的HLA-Ⅰ类抗原表达 被引量:4

Expression of HLA-Ⅰ Antigens in Hepatocellular Carcinoma Cell Lines
下载PDF
导出
摘要 为了为肝癌细胞毒性 T细胞疫苗设计、构建及免疫治疗策略的决策提供体外实验研究依据 ,采用免疫细胞化学 L SAB法及流式细胞术观察了体外培养人肝癌细胞的 HL A- 类抗原表达情况。结果显示 ,人肝癌细胞株 Alexander、Hep G2、SMMC- 772 1、QGY- 770 3都有较强的 HL A- 类抗原表达 ,这使细胞毒性 T细胞杀伤肝癌细胞成为可能。 This study was conducted to provide in vitro experimental basis for the decision making of design strategy of hepatocellular carcinoma CTL Vaccine. The expression of HLA Ⅰ antigens in hepatocellular carcinoma cell lines was investigated through flow cytometry and LSAB assay of immunocellular chemistry. The results showed that all the human hepatocellular carcinoma cell lines tested had strong constitutive expression of HLA Ⅰ antigens.These make it possible that cytotoxic T cells can kill the hepatocellular carcinoma cells.
出处 《华西医科大学学报》 CAS CSCD 2000年第4期438-440,共3页 Journal of West China University of Medical Sciences
基金 国家自然科学基金资助项目(批准号 30070855)
关键词 肝癌细胞系 HLA-Ⅰ类抗原 CTL疫苗 免疫治疗 Hepatocellular carcinoma cell lines HLA-Ⅰantigens Flow cytometry Immunocellular chemistry
  • 相关文献

参考文献1

共引文献13

同被引文献52

  • 1谢玲,刘静仪,张佃志,任永生,程淑秀,李竞贤.HLA─Ⅰ类与Ⅱ类抗原在食管癌与肝癌中的分布[J].军事医学科学院院刊,1996,20(1):33-35. 被引量:5
  • 2及和照.肿瘤细胞表面的MHC抗原[J].国外医学(免疫学分册),1996,19(5):264-266. 被引量:14
  • 3钱斌,戴晓汶,黄晓峰,王金泉,张宝燕,孙国英,周一平.E-CD、EGFR及HLA-DR在肝细胞癌中的表达及意义[J].东南国防医药,2007,9(2):137-139. 被引量:1
  • 4陈兰羽,陈建杰,章晓鹰.上海地区汉族人群肝细胞癌与HLA-DRB1*17等位基因遗传易感性相关的研究[J].浙江医学,2007,29(4):305-306. 被引量:6
  • 5Ferrone S,Marincola F M. Loss of HLA class Ⅰ antigens by melanoma cells : molecular mechanisms, functional significance and clinical relevance [ J ]. Immunol Today, 1995,16 (10) : 487 -494.
  • 6Hicklin D J, Marincola F M, Ferrone S. HLA class Ⅰ antigen downregulation in human cancers: T-cell immunotherapy revives an old story [J]. Mol Med Today,1999,5(4) : 178-186.
  • 7Campoli M, Ferrone S. HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance [ J ]. Oncogene, 2008, 27(45) : 5869-5885.
  • 8Shen Y,Xia M,Zhang J,et al. IRF-1 and p65 mediate upregulation of constitutive HLA-A antigen expression by hepatocellular carcinoma cells[J]. Mol Immunol,2009,46(10) : 2045-2053.
  • 9Grandea A G, Van Kaer L. Tapasin: an ER chaperone that controls MHC class I assembly with peptide [ J ]. Trends Immunol, 2001,22(4) :194-199.
  • 10Maffei A, Papadopoulos K, Harris P E. MHC class Ⅰ antigen processing pathways [ J ]. Hum Immunol, 1997,54 ( 2 ) : 91-103.

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部